Financials data is unavailable for this security.
View more
Year on year International Biotechnology Trust grew revenues 269.31% from 12.06m to 44.54m while net income improved 470.62% from 6.81m to 38.88m.
| Gross margin | 90.12% |
|---|---|
| Net profit margin | 87.29% |
| Operating margin | 87.59% |
| Return on assets | 12.68% |
|---|---|
| Return on equity | 14.07% |
| Return on investment | 14.07% |
More ▼
Cash flow in GBPView more
Cash flow information is not available for International Biotechnology Trust .
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.66 |
|---|---|
| Tangible book value per share | 7.66 |
More ▼
Balance sheet in GBPView more
| Current ratio | 0.4113 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.0809 |
|---|---|
| Total debt/total capital | 0.0748 |
More ▼
Growth rates in GBP
Year on year, growth in dividends per share fell -48.40% while earnings per share excluding extraordinary items rose 506.46%. Additionally, five year annualized dividend per share growth ranks below the industry average relative to its peers.
| Div yield(5 year avg) | 3.75% |
|---|---|
| Div growth rate (5 year) | -11.29% |
| Payout ratio (TTM) | 27.70% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 514.34 |
More ▼
